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Abstract 
Background: Healthcare workers (HCWs) pose a potential risk of transmitting commu-
nicable diseases in the hospital settings where they usually work. This s t u d y   a i m s   t o   d e t e r m i n e  
the current influenza vaccination rates among HCWs in three Middle East countries namely 
United Arab Emirates (UAE), Kuwait and Oman, and also to identify the different variables 
associated with the noncompliance of HCWs to the recommendations of the Advisory 
Committee on Immunization Practices (ACIP) set in those countries. Methods: 1500 ques-
tionnaires were distributed to health care workers in the three countries during the period of 
July-October 2009. Results: Among 993 respondents, the vaccination rate was 24.7%, 67.2% 
and 46.4% in UAE, Kuwait and Oman, respectively. The different motivating factors that in-
f l u e n c e d   t h e   h e a l t h   c a r e   w o r k e r s   t o   t a k e   t h e   v a c c i n e   w a s   a s s e s s e d   a n d   f o u n d   t h a t   t h e   m o s t  
c o m m o n   f a c t o r   t h a t   i n f l u e n c e d   t h e i r   d e c i s i o n   t o   t a k e   t h e   v a c c i n e   w a s  f o r   t h e i r   s e l f   p r o t e c t i o n  
( 5 9 % ) .   O n   t h e   o t h e r   h a n d ,   t h e   m o s t   common reason that discouraged H C W s   t o   t a k e   t h e  
vaccine was “lack of time” as reported by 31.8% of the respondents. Other reasons for not 
taking the vaccine were unawareness of vaccine availability (29.4%), unavailability of vaccine 
(25.4%), doubts about vaccine efficacy (24.9%), lack of information about importance (20.1%) 
and  concerns  about  its  side  effects  (17.3%).  Conclusions:  influenza  immunization  by 
healthcare workers in the studied countries was suboptimal which could be improved by 
setting different interventions and educational programs to increase vaccination acceptance 
among HCWs. 
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INTRODUCTION 
Healthcare  workers  (HCWs)  pose  a  potential 
risk  of  transmitting  communicable  diseases  in  the 
hospital settings where they usually work.1 Healthy 
individuals  who  are  infected  with  influenza  virus, 
including  those  with  subclinical  infections,  can 
transmit influenza virus to other individuals who are 
a t   h i g h e r   r i s k   o f   c o m p l i c a t i o n s   f r o m   i n f l u e n z a 2  i.e. 
elderly and immune-compromised patients. As these 
patient s   b e l o n g   t o   t h e   r i s k   g r o u p s ,   t h e y   m u s t   b e   v a c-
cinated  against  influenza.  Vaccination  rates  among 
t h e s e   g r o u p s   v a r y   w i d e l y   a m o n g   c o u n t r i e s   a n d   e v e n   i f  
v a c c i n a t e d ,   i t   i s   r e p o r t e d   t h a t   t h e   e f f i c a c y   o f   i n f l u e n z a  
v a c c i n a t i o n   a r e   l o w e r   t h a n   t h a t   o f   y o u n g e r   a d u l t s 
which necessities their indirect protection against in-
fluenza infections through vaccinating HCWs.3 
Influenza vaccination of HCW reduces the risk 
of  infection,  influenza-like-illness  and  absenteeism 




fections  and  associated  morbidity  and  mortality 
among  their  patients.5  For  these  reasons,  influenza 
vaccination of HCWs is recommended by The World 
H e a l t h   O r g a n i z a t i o n   ( W H O ) ,   U S   C e n t e r   f o r   D i s e a s e  
Control and Prevention (CDC) and the immunization 
guidelin e s   s e t   b y   m a n y   c o u n t r i e s   to  prevent  the 
transmission  of  influenza  virus  from  HCWs  to  pa-
tients.6 
It  is reported  that  there  is  a  low  uptake  of  in-
fluenza vaccination among HCWs despite the availa-
bility  of  immunization  guidelines  in  many  coun-
tries.7,8  I n   t h e   U S   f o r   e x a m p l e ,   t h e   v a c c i n a t i o n   r a t e  
among HCWs was only 43 % in 2005.8  
Most  of  the  Middle  East  countries  adopt  the 
recommendations and guidelines set by the interna-
t i o n a l   h e a l t h   a g e n c i e s   a n d   p r o v i d e   v a c c i n a t i o n   p r o-
grams to all HCWs against influenza virus both sea-
sonal and pandemic. In the United Arab Emirates for 
example,  in  2009,  the  pandemic  influenza  vaccines 
were distributed to all health care facilities and were 
a v a i l a b l e   f r e e   o f   c h a r g e   t o   t h e   m o s t   v u l n e r a b l e   g r o u p  
based on priorities as follow; pilgrims, adults with 
c h r o n i c   d i s e a s e s ,   H e a l t h   c a r e   w o r k e r s   w h o   a r e   i n   d i-
rect contact with patients with the priority for emer-
gency room (ER), Intensive care unit (ICU), outpatient 
clinics and Primary health centers (PHC) healthcare 
workers.9 However, the rate of influenza immuniza-
tion among HCWs and barriers to influenza vaccina-
t i o n s   a r e   n o t   f u l l y   a d d r e s s ed  in  the  Middle  East 
countries.  
T h e   p u r p o s e   o f   t h e   p r e s e n t   s t u d y   i s   t o   d e t e r m i n e  
the current vaccination rates of HCWs in three Gulf 
countries: United Arab Emirates (UAE), Kuwait and 
Oman and also, to identify the different variables as-
sociated  with  the  noncompliance  of  HCWs  to  the 
recommendations  of  the  Advisory  Committee  on 
Immunization Practices (ACIP) set in these countries. 
T h e   s t u d y   i n t e n d s   t o   a i d   t h e   r e g u l a t o r y   b o d i e s   t o   i m-
plement effective interventions that would raise the 
rate of influenza immunization among HCWs.  
METHODS 
1500 questionnaires were either personally dis-
tributed to HCWs or through their Health Care Facil-
ity (HCF) administrative channels by internal email or 
mail. The questionnaires were randomly distributed 
in  pre-selected  health  care  facilities  i.e.  three  main 
hospitals, five polyclinics and medical centers in each 
country during the period of July-October 2009.  
The  questionnaire  was  delivered  to  the  study 
p o p u l a t i o n s ;   n u r s e s   w o r k i n g   i n   I C U ,   p e d i a t r i c s ,   g e-
riatrics,  acute  medical  care,  gynecology  and  emer-
gency  departments;  doctors,  GPs,  nephrologists, 
dentists, pediatricians and allied health care profes-
sionals i.e. radiographers, laboratory technicians and 
administrators.  
Participants were given a brief introduction on 
t h e   a i m   o f  the study, instructions on how to complete 
the survey and on how to return the completed forms. 
A   p e r i o d   o f   o n e   w e e k   w a s   a l l o w e d   f o r   s u b m i t t i n g   t h e  
completed questionnaire, so as to ensure maximum 
participation of staff working in different shifts.  
The questionnaire assessed HCWs uptake of in-
fluenza  vaccination,  reasons  for  vaccine  uptake for 
vaccinated workers, and reasons for vaccination re-
f u s a l   f o r   t h o s e   w h o   h a d   d e c l i n e d   t a k i n g   t h e   v a c c i n e .  
T h e   q u e s t i o n n a i r e   c o m p o s e d   o f   t w o   p a r t s ;   P a r t   1   a d-
dressed the demographic information of the partici-
pants, history of influenza like symptoms (frequency), 
absence from work due to influenza illness, frequency 
o f   r e c e i v i n g   v a c c i n a t i o n   ( i f   t a k e n   o n   r e g u l a r   b a s i s ) ,  
participants’ knowledge of Centre of Disease Control 
(CDC) recommendations on seasonal influenza. Part 2 
c o m p r i s e d   o f   s u b d i v i s i o n s ,   t h e   f i r s t   g r o u p   o f   q u e s-
tions were addressed to those who had received the 
vaccine  and  enquired  about  reasons  for  taking  the 
vaccine, time of vaccine administration and whether 
vaccine intake was beneficial. 
The second group of questions were addressed 
t o   t h o s e   w h o   d i d   n o t   r e c e i v e   t h e   i n f l u e n z a   v a c c i n a-
tion, and assessing different factors that might have 
inhibited their influenza vaccine uptake. 
The  study  protocol  was  approved  by  the  Re-
search  and  Ethics  Committee  at  Dubai  Pharmacy 
College and approval for distributing the question-
naire  was  obtained from  the  administration  of  each 
health care facility (HCF) participated in the survey. 
The  study  protocol  was  also  approved  by  internal 
committees of the participated health care facilities. 
Data Analysis 
Data  were  entered  and  analyzed  using  SPSS 
software version 17; (SPSS®, Inc, Chicago, IL). Statis-
tical analyses were performed using χ2 tests for com-
parison between bivariate variables. Multivariate lo-
gistic-regression analysis was conducted to examine 
the  associations  between  the  outcome and all  inde-
pendent variables.  
RESULTS 
Of the 1500 distributed questionaiers, 993 HCWs 
completed and returned the questionnaire with a total 
response  rate  o f   6 6 . 2 %   i n   t h e   t h r e e   M i d d l e   E a s t  
countries with the highest response rate from Kuwait; 
where  300  questionairre  were  distributed  and  232 
(77.3%)  completed  the  questionairre.  In  Oman,  600 
questionairre  were  distributed  and  360  (60%) 




distributed and 401(58%) had completed and returned 
the  survey.  Approximately,  seventy  percent  of  the 
respondents were in the age range of 25- 4 5   y e a r s   w i t h  
the majority of the respondents being female (65.4%). 
The  majority  of  the  participants  (66.5%)were 
p r o f e s s i o n a l   s t a f f .   D a t a   o n   t h e   d e m o g r a p h i c  
information of participants are summarized in Table 
1. 
T h e   s t u d y   r e s u l t s   s h o w e d   t h a t   a   t o t a l   o f   4 2 . 5 %   o f  
all the respondents self reported influenza vaccination 
in  the  three  countries.  There  was  a  statistically 
s i g n i f i c a n t   d i f f e r e n c e   i n   t h e   r a t e   o f   v a c c i n a t i o n   a m o n g  
participants  in  the  three  countries  (p-value  <0.0001) 
with  the  highest  vaccination  rate  in  Kuwait  (67.2%) 
compared to 46.4% in Oman and only 24.7% in UAE. 
A small proportion of the respondents reported 
t h a t   t h e y   g o t   i n f l u e n z a   l i k e   s y m p t o m s   o n   r e g u l a r   b a s i s  
(11.6%) and the majority of the participants reported 
that they got it rarely (53.0%). When the respondents 
were  asked  about  their  awaeness  of  the  CDC 
recomendations  for  influenza  vaccination,  around 
fifty one percent of the respondents reported that they 
are  aware  of  the  CDC  recommendations  regarding 
immunization  against  seasonal  influenza.  Data  are 
summarized in table 1. 
The  association  between  the  respondents’ 
charactarestics and the vaccination status were tested 
to identify the different variables associated with the 
likelihood  of  vaccination  aganist  influenza  among 
HCWs. The data are summarized in table 2.   T h e r e  was 
no significant association between HCWs age and the 
v a c c i n a t i o n   s t a t u s   i n   b o t h   U A E   a n d   K u w a i t   w i t h   a  
p-value > 0.05 (χ2test)  with  highest  vaccination  rate 
being  within  the  age  range  of  >  45  years  (32.2%)in 
UAE and within the age range of 36-45 years of age 
(69.5%) in Kuwait.In Oman, there was a significant 
difference in the vaccination rate among the different 
age groups (P = 0.005) with the age range of 36-45 
years of age (56.3%) having the highest vaccination 
rate. The lowest vaccination rate was within the age 
range below 25 years of age(25.5%). 
R e s u l t s   a l s o   s h o w e d   t h a t   g e n d e r   d o e s   n o t   h a v e  
any statistically significant effect on  the  vaccination 
r a t e   o f   t h e   p a r t i c i p a n t s   w i t h   a   p-value = 0.05 (χ2 test) in 
the three participated countries. 
The attitude of HCWs ’   w e r e   a l s o   a n a l y z e d   t o   s e e  
i f   t h e i r   d e c i s i o n   t o   t a k e   i n f l u e n z a   v a c c i n a t i o n   w e r e   i n  
a n y   w a y   i n f l u e n c e d   b y   t h e i r   p r e v i o u s   h i s t o r y   o f   i n-
fliction with influenza like symptoms. Results  from 
UAE and Kuwait showed that there is no association 
between  respondents’ previous history of influenza 
illness and their vaccination status (p-value > 0.05, χ2 
test)  in  fact  i n   O m a n ,   t h e   h i g h e s t   v a c c i n a t i o n   r a t e  
(66.4%) was obtained for individuals who never got 
influenza like symptoms. Multivariate analysis of the 
results showed that having history of influenza illness 
w a s   l e s s   l i k e l y   t o   o c c u r   i n   t h e   v a c c i n a t e d   g r o u p   i n  
Oman (OR=0.662). Data are shown in table 2. 
 
 
Table 1. Characteristics of respondent to the influenza vaccine survey of health care workers (**: Significance level < 0.005) 









Age  <25yrs  31 (7.7)  3 (1.6)  47 (13.1)  79 (8.0) 
25-35yrs  163 (40.6)  18 (7.8)  170 (47.2)  351 (35.3) 
36-45yrs  120 (29.9)  141 (60.7)  87 (24.2)  350 (35.2) 
>45yrs  87 (21.7)  70 (30.2)  56 (15.6)  213 (21.5) 
Gender  Male  115 (28.8)  107 (46.1)  122 (33.9)  344 (34.6) 
Female  286 (71.2)  125 (53.9)  238 (66.1)  649 (65.4) 
Professional group  Professionals  224 (55.9)  182 (78.4)  254 (70.6)  660 (66.5) 
Paramedic  103 (25.7)  43 (18.5)  46 (12.8)  192 (19.3) 
Other  74 (18.5)  7 (3.0)  60 (16.7)  141 (14.2) 
Previous history of Influenza  Never  160 (39.9)  76 (32.8)  116 (32.2)  352 (35.4) 
Regularly   41(10.2)  33 (14.2)  41 (11.4)  115 (11.6) 
Rarely   200 (49.9)  123 (53.0)  203 (56.4)  526 (53.0) 
Awareness of CDC recom-
mendation  
Yes  195 (48.6)  110 (47.4)  177 (49.2)  482 (48.5) 
No  206 (51.4)  122 (52.6)  183 (50.8)  511 (51.5) 
Vaccination  Vaccinated  99(24.7)  156(67.2)  167(46.4)  422 (42.5)** 
Total     401  232  360  993 
 
 




T a b l e   2 . Bivariate analysis of association between vaccination status and respondent characteristics and multivariate analysis 
of likelihood of vaccination. 





















Age  <25  13  87.1    33.3  66.7    25.5  74.5    0.788 
(0.614-1.011) 
25-35  22.1  78    50  50    44.7  55.3     
36-45  25.8  74.2    69.5  30.5    56.3  43.7     
>45  32.2  67.8  0.131  65.7  34.3  0.326  53.6  46.4  0.005   
Gender  Male  29.6  70.4    62.6  37.4    48.4  51.6     
Female  22.7  76.9  0.156  71.2  28.8  0.165  45.4  54.6  0.591   
Professional 
group 
Professionals  26.3  73.7    75  25    50  50     
Paramedic  25.2  74.8    70  30    34.8  65.2     
Others  18.9  81.1  0.434  57.1  42.9  0.798  40  60  0.090   
Previous in-
fluenza history 
Never  18.8  81.3    63.2  36.8    66.4  33.6     
Regularly  24.4  75.6    63.6  36.4    51.2  48.8     




Yes  70.1  29.9    66  34    60.2  39.8     




Yes  26.7  73.3    65.5  34.5    56.5  43.5     




On  the  other  hand,  the  s t u d y   s h o w e d   t h a t   i n-
fluenza vaccinated healthcare workers often continue 
to  work  while  getting  sick  with  influenza  illness 
c o m p a r e d   t o   n o n e   v a c c i n a t e d   i n d i v i d u a l s .   I n   U A E ,  
there was a significant difference (p-value =0.05) ob-
served between the vaccination status of the respon-
d e n t s   w h o   c o n t i n u e   t o   w o r k   d e s p i t e   t h e i r   i n f e c t i o n  
with influenza (70.1%). 
Participants’ awareness of the CDC recommen-
dations of vaccination against seasonal influenza were 
a s s e s s e d   w h i c h   r e v e a l e d   t h a t   a l m o s t   h a l f   o f   t h e   p a r-
ticipants  (48.5%) were aware of these recommenda-
tions. Despite this fact, the vaccination rate was low in 
a l l   t h e   t h r e e   c o u n t r i e s ;   i n   U A E ,   o n l y   2 6 . 7 %   o f   t h e   v a c-
cinated workers were aware of the CDC recommen-
d a t i o n s .   I n   O m a n ,   t h e   m a j o r i t y   o f   t h e   v a c c i n a t e d   i n-
dividuals  (5 6 . 5 % )   w e r e   a w a r e   o f   t h e   C D C   r e c o m-
mendations  and  those  HCWs  were  2.2  times  more 
l i k e l y   t o   h a v e   b e e n   v a c c i n a t e d   t h a n   o t h e r s .  Data are 
summarized in table 2. 
The different motivating factors that influenced 
t h e   h e a l t h   c a r e   w o r k e r s   t o   t a k e   t h e   v a c c i n e   w a s   a s-
se s s e d   a n d   f o u n d   t h a t   t h e   m o s t   c o m m o n   f a c t o r   t h a t  
i n f l u e n c e d   t h e i r   d e c i s i o n   t o   t a k e   t h e   v a c c i n e   w a s   f o r  
t h e i r   s e l f   p r o t e c t i o n   ( 5 9 % ) .   4 6 . 9 %   t o o k   t h e   v a c c i n e  
b a s e d   o n   t h e   r e c o m m e n d a t i o n s   s e t   b y   t h e i r   i n s t i t u-
tions and 45.5% of HCWs took the vaccine to protect 
their patients and other HCWs from getting infected 
with influenza virus. The motivating factors that in-
fluenced  HCWs’  decision  to  take  influenza  vaccine 
w e r e   s i m i l a r   i n   a l l   t h e   t h r e e   c o u n t r i e s .   T h e   o n l y   f a c t o r  
that showed statistically significant difference among 
the three countries was accessibility of the concerned 
vaccine where 38.3% and 42.9% of the respondents in 
Oman  and  Kuwait  respectively  reported  that  they 
took  the  vaccine  because  it  was  easily  accessible 
compared to (12.1%) in UAE (p-value= 0.049, χ2 test). 
Data are summarized in Table 3. 
On the other hand, self reported reasons among 
HCWs on refusal to take influenza vaccine were as-
sessed and showed that the most common reason that 
discouraged HCWs to take the vaccine was “lack of 
time” as report e d   b y   3 1 . 8 %   o f   t h e   r e s p o n d e n t s .   O t h e r  
r e a s o n s   f o r   n o t   t a k i n g   t h e   v a c c i n e   w e r e  unawareness 
of vaccine availability (29.4%), unavailability of vac-
cine (25.4%), doubts about vaccine efficacy (24.9%), 
lack  of  information  about  importance  (20.1%)  and 
concerns a b o u t   i t s   s i d e   e f f e c t s   ( 1 7 . 3 % ) .  Data is shown 
in table 4. 
T h e   m o s t   c o m m o n   r e a s o n   f o r   n o t   t a k i n g   t h e  
vaccine  in  UAE  &  Oman  was  the  unawareness  of 
vaccine  availability (21.5%  and 31.6%,  respectively) 
while in Kuwait “lack of time” was the main reason 
for not being vaccinated (90.9%) among HCWs. 
The most common reasons among HCWs for not 
t a k i n g   t h e   v a c c i n e   w e r e   s i m i l a r   i n   t h e   t h r e e   c o u n t r i e s  
but there were statistically significant differences for 
s o m e   f a c t o r s   a m o n g   t h e   t h r e e   c o u n t r i e s .   H C W s ’   a p-
prehensions of experiencing side effects was more in 
UAE (19.5%) compared to 13.2% and 15.5% in Kuwait 
and Oman, respectively. Lack of time was extremely 




pondents from Kuwait (90.9%) t o   b e   t h e   m a i n   r e a s o n  
for  not  taking  the  vaccine  compared  to  14.6%  and 
19.7% in UAE and Oman, respectively. Another factor 
was HCWs doubts regarding vaccine efficacy as re-
p o r t e d   i n   K u w a i t   b y   5 6 . 6 %   o f   t h e   r e s p o n d e n t s   w i t h   a  
significant p-value < 0.05, χ2 test compared to 20.9% 
and 18.7% in UAE a n d   O m a n ,   r e s p e c t i v e l y .   A l l   o t h e r  
factors were of non-significant difference among the 
respondents from the three participated countries. 
Table 3. Reasons for up-taking vaccine among health care 
workers in three countries.  









Advanced age(>50)  8.1  6.4  4.8  6.1  0.845 
Easy access to vaccina-
tion 
12.1  42.9  38.3  40  0.049 
Recommendations from 
guidelines 
40.4  50  47.9  46.9  0.837 
Reduce illness period  28.3  35.3  35.9  33.9  0.791 
Benefits out-weigh risks 
of side effects 
8.1  11.5  14.4  11.8  0.674 
Self protection  56.6  54.5  64.7  59  0.109 
patients and workers 
Protection  
32.3  46.2  52.7  45.5  0.241 
Influenza epidemic  25.2  28.8  24.0  26  0.912 
 
 
Table 4. Reasons for not-taking vaccine among health care 
workers in three countries. 









Side effects  19.5  13.2  15.5  17.3  0.000 
Lack of time  14.6  90.9  19.7  31.8  0.000 
Doubts about efficacy   20.9  56.6  18.7  24.9  0.016 
Lack of information 
about importance 
16.6  32.9  20.7   20.1  0.638 
Unavailability of vaccine  19.5  44.7  26.9  25.4  0.930 
Low risk of infection  13.6  26.3  11.4  14.5  0.125 
Unaware of availability 
or access to vaccine 
21.5  55.3  31.6  29.4  0.912 
It transfer influenza 
virus 
1.6  3.9  2.6  2.2  0.971 
Financial reasons  4.3  9.2  3.1  4.6  0.393 
  
DISCUSSION 
Influenza vaccination of HCWs is cost effective, 
reduces  the  productivity  losses  associated  with  in-
fluenza illness and minimizes the transmission of the 
disease from HCWs to their patients. Many studies 
prove  the  effectiveness  of  influenza  vaccination  in 
reducing  illness  absenteeism  and  improving  health 
status among health care workers. 10 
The present study was conducted to assess the 
attitudes of HCWs toward influenza vaccination and 
the extent of uptake of vaccination among health care 
workers employed in hospitals and clinical settings in 
certain Gulf countries. 
The results of the present study revealed that the 
vaccination rate in UAE (27%) was low compared to 
46.4% in Oman and 67.2% in Kuwait. This low vacci-
nation rate is comparable to findings reported from 
various  studies  done  in  different  countries.  In  one 
study conducted in US hospital setting, the vaccina-
tion  rate  among  HCWs  working  in  the  emergency 
department  was  28%.11  In  another  study  done  in 
Australia, the percentage of vaccine recipients among 
HCWs was only 22%. However, a similar study done 
i n   S a u d i   A r a b i a ,   a n o t h e r   G u l f   c o u n t r y ,   r e p o r t e d   t h a t  
almost half of HCW’s who participated in the study 
were vaccinated regularly. 12  
The  highest  vaccination  rate  was  reported  in 
K u w a i t   ( 6 7 . 2 % )   d e s p i t e   t h e   f a c t   t h a t   a l m o s t   h a l f   o f   t h e  
respondents in the three countries were aware of the 
CDC  recommendations  which  indicate  that  more 
compliance  to  the  CDC  recommendations  was  the 
highest in Kuwait compare Oman and UAE.  
There  are  several  factors  which  may  influence 
influenza  vaccination  acceptance  among  HCWs. 
F i n d i n g s   f r o m   t h e   c u r r e n t   s t u d y   s u g g e s t s   t h a t   i f   a  
HCW gets vaccinated against influenza; he would do 
s o   m o r e   o f t e n   f o r   h i s   s e l f   p r o t e c t i o n   r a t h e r   t h a n   t o  
prevent  the  transmission  of  disease  to  the  patients. 
T h i s   r e s u l t   i s   i n   c o n s i s t e n c e   w i t h   o t h e r   s t u d i e s   t h a t  
i d e n t i f i e d   t h e   m a i n   r e a s o n   f o r   t a k i n g   t h e   v a c c i n e s   b y  
HCWs to be for self protection. 12,13 However, a study 
conducted in Australia revealed that the most impor-
tant  rea s o n   f o r   v a c c i n e   u p t a k e   w a s   t o   p r o t e c t   t h e i r  
patients  against  transmission  of  the  disease,  where 
almost  three  quarters  of  the  participants  identified 
p a t i e n t   p r o t e c t i o n   t o   b e   t h e   m a i n   r e a s o n   f o r  taking up 
the influenza vaccination.13 
The  study  demonstrated  that  almost  51.5%  of 
t o t a l   p a r t i c i p a n t s   d i d   n o t   t a k e   t h e   v a c c i n e   e v e n   t h o u g h  
they were updated on the CDC’s  recommendations 
w i t h   r e g a r d   t o   i n f l u e n z a   v a c c i n a t i o n .   T h i s   s h o u l d   i n-
vite the attention of concerned parties on the need to 
implement appropriate strategies intended to reduce 
vaccination rejection by HCWs.  
The results from this study demonstrated that in 
U A E   a n d   O m a n ,   t h e   m a i n   r e a s o n   f o r   n o t   t a k i n g   t h e  
vaccine  was  the  unawareness  on  the  availability  or 
l i m i t e d   a c c e s s   t o   t h e   v a c c i n e ;   w h i l e   i n   K u w a i t   9 0 . 9 %   o f  
respondents attributed lack of time for not taking the 
vaccine. HCFs should facilitate easy access for HCWs 
t o   t h e   i n f l u e n z a   v a c c i n e s   a t   t h e i r   w o r k   p l a c e ,   w h i c h  
would increase the vaccination rate and subsequently 
contributing to improved compliance to the vaccina-
tion program.  
T h e r e   a r e   s e v e r a l   r e a s o n s   f o r   l a c k   o f   v a c c i n e   u p-
take by HCWs which are numerically large and hete-




by itself is important as it reveals the complexity of 
the situation and indicates that it is crucial to under-
s t a n d   t h e   b a r r i e r s   t o   v a c c i n a t i o n   w h i c h  m a y   b e   s p e-
cific to a particular cultural setting and/or subgroups 
of HCWs.14,15 
Previous history of influenza like symptoms was 
associated with HCWs’ decision to take the vaccine in 
Oman where vaccinated individuals were less likely 
to have a history of influenza illness. This is an en-
couraging finding which should be considered by all 
HCWs  to  increase  their  vaccination  acceptance  for 
more self protection against influenza illness.  
Professional health care organizations must de-
velop internal policies and provide educational/ in-
formational  resources  to  support  HCWs  influenza 
immunization program. These resources must specif-
ically  address  the  benefits  and  safety  of  influenza 
vaccines as well as the potential adverse health con-
sequences on themselves, their family members and 
patients, if infected with influenza illness. Regulatory 
bodies must organize different educational programs 
and  vaccination  campaigns  to  improve  HCWs’ 
awareness  on  influenza  vaccination.  To  increase 
HCWs’  compliance  to  influenza  vaccination,  HCFs 
should  implement  appropriate  follow  up  and  re-
minder  systems  which  w o u l d   b e   s u c c e s s f u l   i n   i n-
creasing HCWs’ compliance to vaccination. Previous 
studies reported that educational materials addressed 
to  HCWs  are  very  important  in  improving  their 
awareness,  however,  multi-faceted  interventions  in-
cluding  sending  messages,  developing  evidence 
b a s e d   p o l i c i e s   a n d   c o n s e n s u s   h a v e   b e e n   f o u n d   t o   h a v e  
a much bigger impact to change HCWs behavior.14,15 
HCFs must also implement various other inter-
ventions to increase the vaccination rate. To maximize 
convenience  and  minimize  the  disruption  of  usual 
clinical activities, the ACIP recommends the following 
measures to increase vaccination acceptance among 
h e a l t h   c a r e   w o r k e r s ;   t h e   u s e   o f   m o b i l e   c a r t s   t o   d e l i v e r  
the  vaccine  onsite  to  healthcare  workers  in  their 
workplace, increase vaccine availability after regular 
daytime hours, and follow up vaccination programs 
e a r l y   d u r i n g   t h e   c o u r s e   o f   r e c o g n i z e d   c o m m u n i t y  
outbreaks.6 
Many  health  care  organizations  in  the  studied 
countries had conducted various influenza immuni-
z a t i o n   p r o g r a m s ,   b u t   t h e   i m p a c t   o f   t h e s e   p r o g r a m s   o n  
t h e   v a c c i n a t i o n   r a t e s   h a d   n o t   b e en  remarkable.  A 
comprehensive, concerted joint effort is to be initiated 
by employers, health care institutions, voluntary or-
ganizations  and  regulatory  authorities,  to  improve 
a n d   s u s t a i n   h e a l t h   c a r e   w o r k e r   i n f l u e n z a   v a c c i n a t i o n  
rates at optimal levels.  
Limitations of the study 
Despite the fact that the response rate was good 
t h e   s t u d y   h a s   s o m e   l i m i t a t i o n s   i n   r e s p e c t   t o   t h e   s m a l l  
sample  size  approached  according  to  participants’ 
a r e a   o f   s p e c i a l i z a t i o n   i n   t h e   s t u d i e d   c o u n t r i e s .   I n   a d-
dition,  the  questionnaire assessed self reported vac-
c i n a t i o n   r a t e   a n d   a r e   n o t   b a s e d   o n   c h a r t   r e v i e w   w h i c h  
may  resulted  in  a  biased  over  reported  vaccination 
rate.  
CONCLUSION 
In summary, the uptake of influenza immuniza-
t i o n   b y   h e a l t h c a r e   w o r k e r s   i n   t h e   s t u d i e d   c o u n t r i e s  
namely  UAE,  Kuwait  and  Oman  was  suboptimal, 
which could be improved by setting different inter-
ventions  and  educational  programs  to  increase 
awareness among health care workers on the benefits 
o f   v a c c i n a t i o n .   U n d e r s t a n d i n g   t h e   b a r r i e r s   t o   a n d   f a-
cilitators of influenza  vaccine  uptake by  HCWs are 
a l s o   e s s e n t i a l   t o   o v e r c o m e   t h e i r   l o w   c o m p l i a n c e .   F u r-
thermore, ensuring vaccines availability and accessi-
bility, particularly at their work place are other sig-
nificant  factors  that  would  improve  the  acceptance 
and compliance to the immunization program. 
Vaccination  acceptance  rate  could  also  be  in-
c r e a s e d   b y   c o n d u c t i n g   p r o m o t i o n a l   c a m p a i g n s   w i t h  
regular  follow  up  and  appropriate  individual  re-
minder systems such as an email alert or an intranet 
l i n k   t h a t   w o u l d   d i s p l a y   w h e n   a n d   w here  influenza 
vaccination  is  available.  Additionally,  establishing 
internal policies and procedures for HCFs regarding 
vaccination recommendations is of great importance 
which would substantially influence HCWs behavior 
and contribute to improving their influenza vaccina-
tion uptake. 
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